Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Study duration (in years) per indication over the past two decades

From: Pipeline progress and portfolio management of the top 30 pharma companies over the past two decades

Indications

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

Mean

(by indication)

SD

(by indication)

CARD

3.7

2.5

1.9

2.4

1.4

1.3

1.4

1.3

1.3

2.0

1.6

1.5

1.3

1.6

1.9

1.0

1.8

1.9

2.2

1.6

1.5

1.8

0.6

DERM

0.6

2.8

2.0

2.0

1.6

1.2

1.6

1.6

0.9

1.0

2.8

1.4

2.6

1.2

1.7

1.2

1.5

2.3

2.4

2.4

2.1

1.8

0.6

HAEM

4.4

3.6

2.5

2.8

1.7

1.1

1.7

2.3

2.0

2.2

3.4

1.6

1.7

3.5

3.0

0.9

1.4

2.3

2.2

2.1

2.7

2.3

0.9

HORM

8.0

2.6

 

4.7

3.0

1.5

1.2

1.2

1.1

0.9

0.7

 

0.7

1.1

3.4

0.7

 

1.6

  

1.2

2.1

1.9

INFEC

3.5

3.1

2.8

3.0

2.5

2.1

1.7

1.8

1.8

1.7

1.6

1.9

1.6

1.8

1.5

1.9

2.0

2.0

1.5

2.0

2.1

2.1

0.5

META

2.4

2.1

1.7

1.4

1.7

1.6

1.5

1.2

1.3

1.3

1.3

1.3

1.5

1.2

1.8

1.9

1.5

1.8

2.1

2.1

1.9

1.6

0.3

MUSCO

2.1

4.1

3.1

1.2

1.8

2.0

1.6

1.8

2.9

1.9

2.4

1.6

2.4

3.0

2.6

2.2

2.2

2.7

1.8

3.7

2.0

2.3

0.7

NEURO

3.4

2.8

2.3

2.0

1.7

1.7

1.9

1.4

1.6

1.6

1.6

2.1

1.7

1.8

1.8

2.0

2.1

2.9

2.6

2.0

2.5

2.1

0.5

ONCIM

7.2

3.9

3.9

3.5

3.5

3.9

4.1

3.4

3.7

3.6

3.3

3.2

3.7

3.5

3.7

4.1

3.6

3.9

3.8

4.3

4.3

3.9

0.8

PARA

                       

RESP

3.4

2.2

1.4

1.7

1.6

1.5

1.6

0.9

0.7

1.2

0.9

1.1

1.4

1.3

1.4

1.3

1.3

1.4

1.3

2.0

1.5

1.5

0.5

SENS

0.3

0.8

0.7

1.0

1.0

0.7

0.7

0.7

0.7

1.1

0.8

1.4

0.8

1.3

1.2

2.5

0.9

0.6

1.1

2.7

1.6

1.1

0.6

URO

2.8

4.5

2.9

1.7

1.9

2.4

1.8

1.6

1.7

2.0

1.2

1.7

1.5

1.9

2.2

1.2

1.8

2.1

0.8

1.4

2.4

2.0

0.7

VAR

2.3

0.9

1.9

1.6

2.6

1.7

1.8

0.7

0.8

0.4

2.0

2.7

0.9

0.7

0.8

1.4

2.0

1.8

1.2

1.2

1.3

1.5

0.6

Mean (by year)

3.4

2.8

2.3

2.2

2.0

1.7

1.7

1.5

1.6

1.6

1.8

1.8

1.7

1.8

2.1

1.7

1.8

2.1

1.9

2.3

2.1

  

SD (by year)

2.1

1.1

0.8

1.0

0.7

0.7

0.7

0.7

0.9

0.8

0.9

0.6

0.8

0.9

0.8

0.9

0.6

0.8

0.8

0.9

0.8